This website uses cookies to ensure you get the best experience on our website.
- Table of Contents
, No Gclids
Disease Info Card
Heparin-induced Thrombocytopenia
Information about Heparin-induced Thrombocytopenia: characteristics, related genes and pathways, plus antibodies you can use for research. This page is being enriched constantly, if you see some information you would like this page to include please send your suggestions to us.
Overview of Heparin-induced Thrombocytopenia
Most recent studies have shown that Heparin-induced Thrombocytopenia shares some biological mechanisms with acute-coronary-syndrome, arterial-thrombosis, blood-coagulation-disorders, cerebrovascular-accident, deep-vein-thrombosis, embolism, hemorrhage, heparin-induced-thrombocytopenia-(hit), infarction, kidney-failure, myocardial-infarction, pulmonary-embolism, thromboembolism, thrombophilia, thrombophlebitis, thrombosis, thrombus, venous-thromboembolism, venous-thrombosis.
Among the many pathways, these few ones have gauged particular interests from scientists studying Heparin-induced Thrombocytopenia, and have been seen in publications frequently: Anaphylaxis, Angiogenesis, Blood Coagulation, Cell Activation, Cell Adhesion, Coagulation, Excretion, Fibrinolysis, Glomerular Filtration, Hemostasis, Hypersensitivity, Immune Response, Pathogenesis, Platelet Activation, Platelet Aggregation, Response To Heparin, Sensitization, Sulfation, Thrombocyte Activation, Wound Healing
Quite a number of genes have been found to play important roles in Heparin-induced Thrombocytopenia, such as ACOT7, ACTG1, ACTG2, APBB3, CPB1, F10, F2, F3, FHL5, MSR1, PF4, PPBP, SELP, SERPINA3, SERPINA5, SERPINC1, SRA1. See what Boster has to offer for the research of these genes by clicking the gene name links below and view a more detailed info card/product listing for that gene.
In a later update, we will include information such as current drugs and therapy solutions as well as on-going and past clinical trials for this disease. Plesae stay updated.